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Abstract
Objective: Multimorbidity is a common problem in the elderly that is significantly associated with higher mortality,
increased disability and functional decline. Information about interactions of chronic diseases can help to facilitate
diagnosis, amend prevention and enhance the patients’ quality of life. The aim of this study was to increase the knowledge
of specific processes of multimorbidity in an unselected elderly population by identifying patterns of statistically
significantly associated comorbidity.
Methods: Multimorbidity patterns were identified by exploratory tetrachoric factor analysis based on claims data of 63,104
males and 86,176 females in the age group 65+. Analyses were based on 46 diagnosis groups incorporating all ICD-10
diagnoses of chronic diseases with a prevalence $ 1%. Both genders were analyzed separately. Persons were assigned to
multimorbidity patterns if they had at least three diagnosis groups with a factor loading of 0.25 on the corresponding
pattern.
Results: Three multimorbidity patterns were found: 1) cardiovascular/metabolic disorders [prevalence female: 30%; male:
39%], 2) anxiety/depression/somatoform disorders and pain [34%; 22%], and 3) neuropsychiatric disorders [6%; 0.8%]. The
sampling adequacy was meritorious (Kaiser-Meyer-Olkin measure: 0.85 and 0.84, respectively) and the factors explained a
large part of the variance (cumulative percent: 78% and 75%, respectively). The patterns were largely age-dependent and
overlapped in a sizeable part of the population. Altogether 50% of female and 48% of male persons were assigned to at
least one of the three multimorbidity patterns.
Conclusion: This study shows that statistically significant co-occurrence of chronic diseases can be subsumed in three
prevalent multimorbidity patterns if accounting for the fact that different multimorbidity patterns share some diagnosis
groups, influence each other and overlap in a large part of the population. In recognizing the full complexity of
multimorbidity we might improve our ability to predict needs and achieve possible benefits for elderly patients who suffer
from multimorbidity.
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Introduction
Multimorbidity is a common problem in the elderly and its
occurrence rises with age. Medicare data suggest that 32% of the
population in the age group 65–69 suffer from three or more
chronic conditions. In the age group 80–84 the prevalence of
multimorbidity increased to 52% [1]. 76% of the patients in general
practice have three or more chronic conditions [2]. Multimorbidity
is significantly associated with higher mortality, increased disability,
a decline of functional status and a lower quality of life. It also leads
to a greater extent of health care utilization (costs, length of hospital
stay, and number of physician visits) [3]. The general practitioner
(GP) has little help in adjusting care for multiple chronic conditions,
because clinical practice guidelines are mostly focused on one
disease only. Adhering to current clinical practice guidelines in the
treatment of multimorbidity may therefore even have adverse
effects [4]. Information about the specific elements and processes in
multimorbidity, the interactions and possible synergies of the
diseases is urgently needed in order to facilitate diagnosis, amend
prevention, lower costs in health care systems and increase the
patients’ quality of life.
According to Schellevis, multimorbidity may be classified by the
relationship between the different diseases. Concurrent comorbid-
ity defines the random coexistence of diseases. Cluster comorbidity
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indicates statistically significant associations between diseases
without a causal explanation. Causal comorbidity describes disease
clustering with a pathophysiological relation between the different
diseases (e.g. shared risk factors). And finally, complicating
comorbidity illustrates the case when one disease is caused by
another disease and cannot be explained without its precursor [5].
If we try to understand the distribution of diseases in
multimorbidity we face a labyrinth full of possibilities. All diseases
are more or less statistically associated with each other. So if we
start at any point of this labyrinth and we have no guide to find
our way, we might easily get lost. For that reason, it seams
important to discover the underlying structure in the distribution
of disease combinations, i.e. which pathways may lead through the
labyrinth of multimorbidity.
The aim of this paper is therefore to separate concurrent
(random) comorbidity from significantly associated comorbidity by
identifying multimorbidity patterns in the distribution of chronic
diseases and to analyze age and gender-specific differences in the
patterns.
Methods
The analyses are based on ambulatory data of the Gmünder
ErsatzKasse, a German statutory health insurance company with
1.7 million insurants (in 2008), which corresponds to 2.4% of the
statutory insured population [6]. The Gmünder ErsatzKasse has a
greater proportion of male insurants in the elderly than in the
general population of Germany therefore data analyses have to be
adjusted for gender. The dataset contains pseudonymous data
from every insured member of this company.
The sample for our analyses consists of all persons aged 65 years
and older who were permanently insured during the year 2006.
For the distribution of age, gender and the number of diagnosis
groups in the sample cf. table 1. The analysis of morbidity was
based on a list of 46 defined diagnosis groups of chronic diseases
(see below) based on ICD-10 (International Statistical Classifica-
tion of Diseases and Related Health Problems, 10th Revision)
codes. The diagnoses were only counted if they were coded in at
least three out of four quarters (three month periods) within the
year 2006. This criterion was chosen in order to increase the
validity of the diagnoses based on claims data by avoiding
transitory or even accidental diagnoses. For prevalence, gender-
specific rank order and ICD-10 codes of the diagnosis groups cf.
table 2.
The methods for compiling the list of 46 diagnosis groups have
been described elsewhere in detail [7]. In short, we used the most
frequent conditions in GP surgeries as mentioned in a panel survey
of the Central Research Institute of Statutory Ambulatory Health
Care in Germany (‘‘ADT-Panel’’) [8]. Chronicity of diagnoses was
assessed using the scientific expert report for the formation of a
morbidity orientated risk adjustment scheme in the German
Statutory Health Insurance [9]. In order to capture a compre-
hensive picture of the disease patterns in individual patients we
amended this list for all chronic conditions with a prevalence $1%
in the age group $65 years in the data set of the Gmünder
ErsatzKasse in 2006. ICD-10 codes were grouped together if
diseases and syndromes had a close pathophysiological similarity
and if ICD codes of related disorders were used ambiguously by
coding physicians in clinical reality, respectively.
The research expressed in our article was conducted according
to the principles expressed in the Declaration of Helsinki. We did
not have to obtain informed consent, because our research was
based on insurance claims data and the data set was analyzed
anonymously (as regulated by German law in 175 SGB X). The
study was approved by the Ethics Committee of the Medical
Association of Hamburg including the waiver of consent (approval
no. PV3057).
Statistical Analyses
Correlations between diagnosis groups were analyzed by
exploratory factor analysis. We chose the principal factor method,
because we presumed that the factors would not explain the whole
variance of the analyzed diagnosis groups. We used a tetrachoric
correlation matrix for factor analysis, which is supposed to be an
appropriate method for dichotomous data [10]. In doing so, we
made the assumption that the dichotomous diagnoses reflect an
underlying continuous latent trait. In other words: we presumed
that the chronic diseases included in our analysis have a
progressive course (i.e. cumulation of risk factors before onset
and/or progression after onset) and they get diagnosed if in this
course a certain threshold is reached. The factors that result from
our analysis can be interpreted as multimorbidity patterns (i.e.
clusters of diagnosis groups frequently associated with each other)
and each factor loading represents the association of the specific
diagnosis group with a pattern. As a measure of model fit we also
reported cumulative percent which describes the proportion of
variance of the diagnosis data that can be explained be the
patterns. The sampling adequacy for performing a factor analysis
was confirmed by assessing the Kaiser-Meyer-Olkin measure for
data of both genders.
Diagnosis groups of male and female patients were analyzed
separately. Gender-specific diagnoses for female patients were
excluded in analyses of male patients and vice versa (cf. table 2).
Factors were regarded as substantial if they had a minimum
eigenvalue of 1.0. A variable was defined to be associated with a
factor if it had a factor loading of 0.25 or more. We defined a
relatively permissive threshold for factor loadings because we
expected a large amount of random associations (i.e. concurrent
comorbidity) between the diagnosis groups. Factors were allowed
to be associated with each other, i.e. we assumed that being in one
multimorbidity pattern may influence the risk of being in another
pattern as well. For this reason we used an oblique (oblimin)
rotation of factor loading matrices.
For the calculation of prevalences of multimorbidity patterns we
assigned individual patients to a pattern if they had diagnoses in at
least three groups with a factor loading of 0.25 on the
corresponding pattern. For analyses of pattern prevalences
negative factor loadings were considered non-instructive and
ignored. Prevalence figures were created using calculated values
and a smoothing plot using lowess prediction with a smoother span
of 0.5. Because of the low number of cases in the age groups $90,
age-specific prevalence rates for these age groups were considered
as non-informative and excluded from these figures.
Data preparation was done with SAS (Version 9.2). Statistical
analyses were made with Stata/MP (version 11.0) and figures were
created using R (version 2.12.0).
Table 1. Sample size, age and number of diagnosis groups by
gender.
Female Male
n (% of total population) 63 104 (42.3) 86 176 (57.7)
Mean age (sd) 72.6 (6.6) 71.4 (5.7)
Mean number of diagnosis groups (sd) 4.4 (3.3) 4.0 (3.3)
doi:10.1371/journal.pone.0015941.t001
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Table 2. Prevalence of diagnosis groups (in %) and rank order for female and male.
Diagnosis group [ICD-10 codes] Female (rank) Male (rank)
1 Hypertension [I10-15] 54.8 (1) 51.2 (1)
2 Lipid metabolism disorders [E78] 34.6 (2) 32.7 (2)
3 Chronic low back pain [M40-45, M47, M48.0-.2, M48.5-.9, M50-54] 34.6 (3) 28.2 (3)
4 Diabetes mellitus [E10-14] 18.3 (6) 21.7 (4)
5 Joint arthrosis [M15-19] 24.4 (4) 16.6 (7)
6 Chronic ischemic heart diseases [I20-21, I25] 13.0 (11) 21.5 (5)
7 Thyroid dysfunction [E01-05, E06.1-.3, E06.5, E06.9, E07] 23.1 (5) 9.3 (14)
8 Severe vision reduction [H17-18, H25-28, H31, H33, H34.1-.2, H34.8-.9, H35-36, H40, H43, H47, H54] 16.5 (7) 13.9 (10)
9 Cancers [C00-26, C30-41, C43-58, C60-97, D00-09, D37-48] 11.3 (13) 15.0 (9)
10 Cardiac arrhythmias [I44-45, I46.0, I46.9, I47-48, I49.1-.9] 11.2 (14) 13.4 (11)
11 Purine/pyrimidine metabolism disorders/Gout [E79, M10] 7.9 (17) 15.6 (8)
12 Lower limb varicosis [I83, I87.2] 16.2 (8) 7.6 (16)
13 Prostatic hyperplasia [N40] 19.3 (6)
14 Asthma/Chronic obstructive pulmonary disease [J40-45, J47] 10.3 (15) 11.3 (12)
15 Atherosclerosis/Peripheral arterial occlusive disease [I65-66, I67.2, I70, I73.9] 7.3 (19) 10.7 (13)
16 Depression [F32-33] 13.0 (10) 5.2 (23)
17 Obesity [E66] 9.4 (16) 7.6 (17)
18 Liver diseases [K70, K71.3-.5, K71.7, K72.1, K72.7, K72.9, K73-74, K76] 7.0 (21) 9.0 (15)
19 Osteoporosis [M80-82] 14.4 (9) 2.4 (35)
20 Chronic gastritis/Gastroesophageal reflux disease [K21, K25.4-.9, K26.4-.9, K27.4-.9, K28.4-.9, K29.2-.9] 7.8 (18) 7.2 (18)
21 Cerebral ischemia/Chronic stroke [G45, I60-64, I69] 5.3 (27) 6.9 (19)
22 Cardiac insufficiency [I50] 7.2 (20) 5.3 (22)
23 Neuropathies [G50-64] 5.7 (24) 5.4 (20)
24 Noninflammatory gynecological problems [N81, N84-90, N93, N95] 12.6 (12)
25 Chronic cholecystitis/Gallstones [K80, K81.1] 6.6 (22) 4.0 (28)
26 Allergies [H01.1, J30, K52.2, K90.0, L23, L27.2, L56.4, T78.1, T78.4, T88.7] 6.1 (23) 4.2 (25)
27 Insomnia [F51, G47] 5.4 (26) 3.8 (29)
28 Renal insufficiency [N18-N19] 2.9 (36) 5.3 (21)
29 Intestinal diverticulosis [K57] 4.5 (29) 4.0 (26)
30 Hemorrhoids [I84] 3.7 (34) 4.5 (24)
31 Somatoform disorders [F45] 5.5 (25) 2.9 (32)
32 Cardiac valve disorders [I34-I37] 3.7 (33) 4.0 (27)
33 Urinary incontinence [N39.3-.4, R32] 5.1 (28) 2.3 (37)
34 Severe hearing loss [H90, H91.0-.1, H91.3, H91.8-.9] 2.8 (37) 3.5 (30)
35 Dementias [F00-03, F05.1, G30-31, R54] 4.0 (30) 2.6 (34)
36 Dizziness [H81-82, R42] 3.8 (32) 2.2 (38)
37 Rheumatoid arthritis/Chronic polyarthritis [M05-06, M79.0] 3.9 (31) 1.7 (40)
38 Urinary tract calculi [N20] 1.4 (42) 3.2 (31)
39 Anemias [D50-53, D55-58, D59.0-.2, D59.4-.9, D60.0, D60.8-.9, D61, D63-64] 2.5 (39) 2.4 (36)
40 Migraine/Chronic headache [G43-44] 3.6 (35) 1.2 (43)
41 Psoriasis [L40] 1.6 (40) 2.1 (39)
42 Anxiety [F40-41] 2.6 (38) 1.1 (44)
43 Sexual dysfunction [F52, N48.4] 2.9 (33)
44 Parkinson’s disease [G20-22] 1.2 (43) 1.4 (42)
45 Tobacco abuse [F17] 0.8 (44) 1.6 (41)
46 Hypotension [I95] 1.6 (41) 0.9 (45)
doi:10.1371/journal.pone.0015941.t002
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Results
Female Patients
For female patients we assessed a Kaiser-Meyer-Olkin measure
of 0.84 which corresponds to a meritorious sampling adequacy of
the data. Factor analysis of diagnosis groups of female patients
resulted in the emergence of three factors (cf. table 3) with a
cumulative percent of 78.0. The first factor can be interpreted as
multimorbidity pattern of cardiovascular and metabolic disorders
[eigenvalue 6.34]. The second factor was named anxiety,
depression, somatoform disorders (ADS) and pain [2.37]. As a
third pattern we identified neuropsychiatric disorders [1.71].
The age dependency of these multimorbidity patterns is shown
in figure 1. Prevalence rates of the cardiovascular/metabolic
(30.4% total prevalence; 18.5% in 65 years old patients to 44.0%
in 89 years old patients) and neuropsychiatric patterns (6.1%;
1.3% to 25.9%) significantly increase with age while the ADS and
pain pattern increases only slightly (33.6%; 29.5% to 36.1%).
In total 50.3% of the female patients in our sample can be
attributed to one or more multimorbidity patterns. The overlap-
ping of patterns related to the total female population is shown in
figure 2. 14.4% of all female patients are exclusively attributed to
cardiovascular/metabolic disorders and no other pattern, 18.5%
exclusively to ADS and pain and 0.6% exclusively to neuropsy-
chiatric disorders. 11.3% of the female patients overlap between
cardiovascular/metabolic disorders and ADS and pain, 1.7%
between cardiovascular/metabolic and neuropsychiatric disorders
and 0.7% between ADS and pain and neuropsychiatric disorders.
An overlapping between all three patterns can be found in 3.0% of
the female patients.
For female patients the proportional overlapping of each
pattern related to the other patterns is shown in figure 3. 47.1%
and 55.1% of all female patients with ADS and pain and
cardiovascular/metabolic disorders, respectively, are only attrib-
uted to this and no other pattern, while another 37.3% and 33.8%,
respectively, are assigned to both patterns simultaneously. Only
10.0% of all female patients with neuropsychiatric disorders refer
to no other pattern, while 28.5% overlap with the cardiovascular/
metabolic disorders and 11.5% with ADS and pain, respectively.
50.0% of neuropsychiatric patients are also assigned to cardio-
vascular/metabolic disorders and ADS and pain at the same time.
Male patients
For male patients we assessed a Kaiser-Meyer-Olkin measure of
0.85, which also corresponds to a meritorious sampling adequacy.
Factor analysis of diagnosis groups of male patients resulted in the
emergence of three factors (cf. table 4) with a total of 75.3
cumulative percent. The first factor can be interpreted as
multimorbidity pattern of ADS and pain [7.14]. As a second
pattern we identified cardiovascular and metabolic disorders
[1.96]. The third factor can be named as neuropsychiatric
disorders [1.75].
The age dependency of these multimorbidity patterns is shown
in figure 4. The prevalence rates of all three patterns significantly
increase with age, i.e. the cardiovascular/metabolic pattern [total
prevalence: 38.9%] from 28.6% in 65 years old patients to 58.0%
in 89 years old patients, the ADS and pain pattern [21.9%] from
16.5% to 30.8% and the neuropsychiatric pattern [0.8%] from
0.1% to 5.6%.
In total 48.2% of male patients are at least assigned to one
multimorbidity pattern. The overlapping of patterns related to the
total male population is shown in figure 5. 25.9% of all male
patients are exclusively attributed to cardiovascular/metabolic
disorders, 9.2% exclusively to ADS and pain and 0.1% exclusively
to NPS. 12.3% of the male patients overlap between cardiovas-
cular/metabolic disorders and ADS and pain, 0.3% between
cardiovascular/metabolic and neuropsychiatric disorders and
0.06% between ADS and pain and neuropsychiatric disorders.
Table 3. Loadings of factors with eigenvalue $1 in diagnosis
groups of female patients.
CMD ADS/P NPS
Eigenvalue 6.34 2.37 1.71
Cumulative percent 47.5 65.2 78.0
- Hypertension .71
- Lipid metabolism disorders .45
- Chronic low back pain .61
- Diabetes mellitus .55
- Joint arthrosis .35
- Chronic ischemic heart diseases .38 .31
- Thyroid dysfunction .27
- Cardiac arrhythmias .28
- Purine/pyrimidine metabolism disorders/Gout .60
- Lower limb varicosis .31
- Asthma/Chronic obstructive pulmonary disease .27
- Atherosclerosis/Peripheral arterial occlusive
disease
.35 .25
- Depression .44 .36
- Obesity .52
- Liver diseases .39
- Osteoporosis .37
- Chronic gastritis/Gastroesophageal reflux
disease
.36
- Cerebral ischemia/Chronic stroke .43
- Cardiac insufficiency .26 .51
- Noninflammatory gynecological problems .52
- Chronic cholecystitis/Gallstones .29
-Allergies .38
- Insomnia .31
- Renal insufficiency .47 .33
- Intestinal diverticulosis .32
- Hemorrhoids .45
- Somatoform disorders .51
- Cardiac valve disorders .31
- Urinary incontinence .49
- Dementias .78
- Dizziness .30 .30
- Rheumatoid arthritis/Chronic Polyarthritis .29
- Urinary tract calculi .28
- Anemias .29
- Migraine/Chronic headache .53
- Anxiety .39
- Parkinson’s disease .56
- Hypotension 2.38 .58
Factor loadings ,.25 have been omitted. CMD: cardiovascular and
metabolic disorders; ADS/P: anxiety, depression, somatoform
disorders and pain; NPS: neuropsychiatric disorders.
doi:10.1371/journal.pone.0015941.t003
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An overlapping between all three patterns can be found in 0.3% of
the male patients.
For male patients the proportional overlapping of each pattern
related to the other patterns is shown in figure 6. Similar to the
pattern structure of female patients, a large part of patients with
cardiovascular/metabolic disorders (66.7%) and ADS and pain
(42.0%) are only attributed to this and no other pattern while 31.6%
and 56.2%, respectively, simultaneously refer to both patterns.
16.3% of male patients with neuropsychiatric disorders are assigned
to this and no other pattern, while 7.1% are also attributed to ADS
and pain, 35.5% to neuropsychiatric and cardiovascular/metabolic
disorders and 41.1% refer at the same time to ADS and pain,
neuropsychiatric as well as cardiovascular/metabolic disorders.
There are considerable differences between the male and female
sample regarding the composition of the multimorbidity patterns.
The biggest gender differences are in the neuropsychiatric pattern,
which includes chronic ischemic heart diseases, atherosclerosis/
peripheral arterial occlusive disease, dizziness, renal insufficiency
and anemia only in the female population. The cardiovascular/
metabolic pattern includes urinary tract calculi only for female
patients while in this pattern chronic stroke, neuropathies, anemia
and tobacco abuse are only present for male patients. Finally, the
ADS and pain pattern includes noninflammatory gynecological
problems and rheumatoid arthritis only for female as well as
prostatic hyperplasia, severe hearing loss, urinary tract calculi and
sexual dysfunction only for male patients.
Discussion
In Greek mythology the goddess Ariadne handed a clew of
thread to Theseus to guide his way back out of the Minotaur’s
labyrinth. In the labyrinth of multimorbidity we also depend on a
guide to find our way. As we have no other clue (or: clew), we must
rely on statistical methods to explore the different pathways, i.e.
the chains of associations in the pool of chronic conditions.
We made the following assumptions on the associations between
the diseases: We supposed that there is a limited number of
multimorbidity patterns (i.e. clusters of diagnosis groups that are
significantly associated with each other). We expected that some
diseases are associated with other diseases, while some diseases are
rather independent of other diseases. We also assumed that some
diseases are part of more than one pattern.
Previous research on multimorbidity patterns used cluster
analyses to identify morbidity patterns [11–13]. At a given
hierarchical level however, this cluster analysis would assign each
disease to only one cluster, while in reality some diseases may be
frequently associated with different patterns. In our data set this
applies to seven diagnosis groups, i.e. depression, dizziness, renal
insufficiency, atherosclerosis/peripheral arterial occlusive disease,
anemias, chronic stroke and cardiac insufficiency. For this reason a
cluster analysis of diseases might have produced an artificial
pattern structure. Instead, a factor analysis fitted better with our
assumptions. For each disease we know the degree of association
with each pattern, so that diseases may become part of one or even
several patterns. If the diseases are rather independent, there is
little factor loading to each pattern.
Usually, the analysis of multimorbidity patterns is based upon a
multimorbid population. This did not seem to be appropriate for
our approach. In the factor analyses based on tetrachoric
correlations, the dichotomous diagnoses were recalculated into
continuous variables (see methods chapter), i.e. the illness data
used for the exploratory analyses also reflect predispositions for
illnesses as assumed by correlations between diagnosis groups. If
we had excluded persons not being multimorbid or having no
diseases at all we might have overestimated correlations between
diagnosis groups and therefore biased the correlation matrix. For
this reason we decided to base the analysis upon all insurants in the
age group 65+ independently of the persons’ number of diseases.
Persons are usually assigned to factors by performing a cluster
analysis with the persons’ individual factor scores [14]. We
Figure 1. Prevalence by age for multimorbidity patterns of
female patients. CMD: cardiovascular and metabolic disorders; ADS/P:
anxiety, depression, somatoform disorders and pain; NPS: neuropsychi-
atric disorders.
doi:10.1371/journal.pone.0015941.g001
Figure 2. Overlapping of multimorbidity patterns (in %)
related to the total female population.
doi:10.1371/journal.pone.0015941.g002
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deviated from this method, because we presumed that the
complexity of overlapping patterns (cf. figures 2 and 5) may not
adequately be expressed by a limited number of clusters (normally
2 to 4). Instead, we assigned patients to a pattern if they had a
diagnosis in at least three pattern-specific groups (cf. section
statistical analyses). In doing so, we were also able to calculate
prevalence rates for multimorbidity patterns and show how often
these patterns overlap in individual patients.
Strengths and weaknesses of the study
This study is the first to apply a factor analysis for identifying
multimorbidity patterns. The factor analysis did perform well with
the given data set. We had a limited number of three factors for
both genders, a good model fit expressed by a high rate of
cumulative percent (75% and 78%, respectively) and a sufficient
sampling adequacy (Kaiser-Meyer-Olkin measure of 0.84 and
0.85, respectively).
A definite strength of our approach relates to a comprehensive
picture of chronic diseases in the individual patients. We included
all highly prevalent chronic conditions ($1% in the age group
65+) into our diagnosis groups. For that reason we are quite sure
that our statistical model is adjusted for noticeable influences of
confounding diagnoses that may bias our results.
Although accidental and transitory diagnoses were excluded, in
some cases diagnoses may be imprecise, ambiguous or incomplete
because they were not clinically verified by trained professionals.
This is a general problem in insurance claims data, but in our
view, the benefits of claims data outweigh their disadvantages: We
are provided with a large unselected population, representing real-
world conditions and including persons living in protected
institutions/nursing homes as well as frail individuals and the
oldest olds, all frequently not included in survey and field studies.
In choosing insurance claims data, we also avoided selection bias
concerning service providers and as a matter of course there is no
recall bias concerning diagnosis data.
Patterns
We found three matchable multimorbidity patterns in both
genders. Altogether 50.3% of female and 48.2% of male persons in
our sample at least belong to one multimorbidity pattern. As the
patterns differed only in singular diseases between men and
women (see below) they are presented together.
The first pattern includes cardiovascular and metabolic
disorders, an association that has long been known and became
more clearly defined in the 1980s, as the term ‘‘metabolic
syndrome’’ was established to designate the cluster of risk factors
and diseases that come together in a single individual. The main
features include insulin resistance (precursor of diabetes), hyper-
tension and obesity [15], all of these conditions are found in this
pattern. Gout was recently shown to be associated with the
metabolic syndrome as well [16]. This coherence can be
interpreted as an example for causal comorbidity, as these diseases
probably tend to co-occur because they share the same risk factors
(e.g. diabetes and gout [17]).
Figure 3. Proportional overlapping of each pattern related to the other patterns for female patients. CMD: cardiovascular and
metabolic disorders; ADS/P: anxiety, depression, somatoform disorders and pain; NPS: neuropsychiatric disorders.
doi:10.1371/journal.pone.0015941.g003
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Table 4. Loadings of factors with eigenvalue $1 in diagnosis
groups of male patients.
ADS/P CMD NPS
Eigenvalue 7.14 1.96 1.75
Cumulative percent 49.5 63.1 75.3
Hypertension .70
Lipid metabolism disorders .49
Chronic low back pain .66
Diabetes mellitus .59
Joint arthrosis .44
Chronic ischemic heart diseases .53
Thyroid dysfunction .27
Cardiac arrhythmias .37
Purine/pyrimidine metabolism disorders/Gout .50
Lower limb varicosis .33
Prostatic hyperplasia .43








Chronic gastritis/Gastroesophageal reflux disease .40
Cerebral ischemia/Chronic stroke .30 .38









Cardiac valve disorders .37
Urinary incontinence .55
Severe hearing loss .27
Dementias .70
Dizziness .37








Factor loadings ,.25 have been omitted. CMD: cardiovascular and
metabolic disorders; ADS/P: anxiety, depression, somatoform
disorders and pain; NPS: neuropsychiatric disorders.
doi:10.1371/journal.pone.0015941.t004
Figure 4. Prevalence by age for multimorbidity patterns of
male patients. CMD: cardiovascular and metabolic disorders; ADS/P:
anxiety, depression, somatoform disorders and pain; NPS: neuropsychi-
atric disorders.
doi:10.1371/journal.pone.0015941.g004
Figure 5. Overlapping of multimorbidity patterns (in %)
related to the total male population.
doi:10.1371/journal.pone.0015941.g005
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The second pattern found in our study covers anxiety,
depression, somatoform disorders and pain. Groups of symptoms
described in this pattern have appeared under different labels like
‘‘food intolerance,’’ [18] ‘‘chronic pain syndrome’’ [19] or
"medically unexplained symptoms," [20] meaning that a definite
medical diagnosis explaining the symptoms is often not established
and a reasonable organic explanation is lacking [21]. While some
of the diseases are clearly psychogenic (e.g. anxiety or depression)
or clearly organic (e.g. arthrosis or osteoporosis), some can be
assigned to mental and/or somatic causes, such as chronic back
pain, gastritis or migraine. The association of anxiety, depression
and somatic symptoms displayed in this pattern is well described
[21]. A depressive or anxiety disorder is reported in about 30% of
patients presenting physical complaints [22]. Others also report a
close connection between anxiety, depression and gastrointestinal
symptoms like gastritis or intestinal diverticulosis [23].
As a third pattern we found a group of diseases mainly
consisting of neuropsychiatric disorders. Most combinations can
be explained by causal comorbidity, such as dementia and
Parkinson’s disease probably being the causes for urinary
incontinence. Other disease connections are more complex, for
example cardiac insufficiency is a risk factor for stroke [24] which
increases the risk for vascular dementia [25]. Another intricate
association may result in the presence of anemia in the female
pattern of neuropsychiatric disorders. There is an increased risk of
carotid atherosclerosis and stroke (and therefore vascular demen-
tia) in patients with renal insufficiency [26], which may also lead to
anemia as a typical result of reduced kidney function [27].
The large overlapping of neuropsychiatric and cardiovascular/
metabolic disorders (cf. figures 3 and 6) may also be explained by
the relation between cardiovascular disorders, stroke and demen-
tia. In addition, the pattern of neuropsychiatric disorders shows
interference with the ADS and pain pattern. This correlation is
well described, e.g. depression is a frequently described comor-
bidity in people after stroke [28] as well as patients with
Alzheimer’s disease or other forms of dementia [29].
Age- and gender-specific differences in patterns
The prevalence of all patterns rises with the age of the patients. As
age per se is the major risk factor for cardiovascular diseases [30]
and metabolic syndrome [31], it is not surprising that the prevalence
of this pattern strongly increases with age. Also, the prevalence of
the pattern with neuropsychiatric disorders gains with increasing
age as expected and already reported elsewhere [32].
Interestingly, there seems to be much less age dependency in the
pattern of anxiety, depression, somatoform disorders and pain.
This might in part be explained by underdiagnosis in older age,
e.g. because older patients with clinically significant mental
disorders tend to underreport their symptoms [33] or because
the focus of doctors might move to manifest somatic diagnoses
with increasing age of patients [34].
There are considerable differences in the composition of the
patterns between the genders. The biggest differences can be
found in the female pattern of neuropsychiatric disorders, which
includes pre-terminal conditions such as chronic ischemic heart
Figure 6. Proportional overlapping of each pattern related to the other patterns for male patients. CMD: cardiovascular and metabolic
disorders; ADS/P: anxiety, depression, somatoform disorders and pain; NPS: neuropsychiatric disorders.
doi:10.1371/journal.pone.0015941.g006
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disease, renal insufficiency and anemia, suggesting an association
of neuropsychiatric disorders and frailty in female patients. This
might also explain the larger growth of this pattern with age in
females than in males.
Gender differences are not always easy to explain. On one
hand, a part of the differences between male and female patterns
belongs to gender-specific morbidity as prostatic hyperplasia and
sexual dysfunction in the male and non-inflammatory gynecolog-
ical problems in the female ADS and pain pattern. On the other
hand, gender differences in prevalence rates might to some extent
account for the different composition of the patterns, e.g.
rheumatoid arthritis exclusively belongs to female pattern of
ADS and pain and has a prevalence in our sample of 3.9% in
female, but only 1.7% in male patients and tobacco abuse
exclusively belongs to the male cardiovascular/metabolic pattern
and has 1.6% in male patients, but only 0.9% in female.
Comparison with other studies
Three other research groups also made efforts to find clusters of
multimorbidity. The results are quite diverse due to differences in
study design and inclusion criteria: The studies differ in data
sources (i.e. administrative data [11], survey data [12] and data
from clinical examinations [13]), populations (e.g. US Veterans
[11] or American Indian elders [12]) and number and type of
diagnosis groups (i.e. 10 conditions including tuberculosis [12], 15
condition including hip fracture [13] or 23 conditions including
HIV, post traumatic stress disorder and schizophrenia [11]). As
mentioned above, all three studies conducted a cluster analysis.
Despite these differences in approach, there are still some
common results in these studies. All studies report a similar cluster
of cardiovascular and related diseases, in one case combined with
metabolic disorders [11] like in our study, in another case
combined with stroke [12] which was also found for male patients
in our study. One other group also found an anxiety/depression
cluster [11], but without the associated somatic disorders we found
in our pattern. The other two studies did not include psychiatric
disorders at all [12] or only in the form of depression [13]. Two
studies included a neuropsychiatric cluster, one combined with
peripheral vascular disease and seizures [11], another combined
dementia, depression and hip fracture [13].
In an overall view, our results fit well with previous evidence.
There are some minor discrepancies to our study, but they can be
explained well by a new approach of identifying multimorbidity
patterns, an unselected patient group and a more comprehensive
list of included diagnosis groups in our study.
Conclusions
The underlying structure of the labyrinth of multimorbidity
sharpens if we allow for a little more complexity. As stated in our
predetermined hypotheses the single multimorbidity patterns seem
to share some diagnosis groups, to influence each other and to
overlap in a large part of the population. We accommodated with
these hypotheses by choosing a factor analysis based on tetrachoric
correlations as our method. Also, it was important to base the
exploratory analysis on an unselected population and a compre-
hensive selection of diagnosis groups to avoid blurring the subtle
ramifications of the labyrinth.
Our clew of thread leads us through three prevalent pathways of
multimorbidity, i.e. clusters of statistically significant co-occur-
rence of chronic diseases. About 50% of all persons of 65 years and
older belong to at least one multimorbidity pattern. The patterns
of cardiovascular/metabolic, neuropsychiatric and anxiety/de-
pression/somatoform disorders and pain fit well with existing
evidence. Research is still needed concerning the impact of the
different patterns. Future studies should especially focus on
interactions between the patterns and (negative) synergy effects
of multiple patterns in individual patients. In recognizing the full
complexity of multimorbidity we might improve our ability to
predict needs and achieve possible benefits for elderly patients who
suffer from multiple chronic conditions.
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